Found: 11
Select item for more details and to access through your institution.
Phase I/IIa clinical trial of a novel hTERT peptide vaccine in men with metastatic hormone-naive prostate cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2017, v. 66, n. 7, p. 891, doi. 10.1007/s00262-017-1994-y
- By:
- Publication type:
- Article
Immunological factors influencing clinical outcome in lung cancer patients after telomerase peptide vaccination.
- Published in:
- Cancer Immunology, Immunotherapy, 2015, v. 64, n. 12, p. 1609, doi. 10.1007/s00262-015-1766-5
- By:
- Publication type:
- Article
Telomerase peptide vaccination: a phase I/II study in patients with non-small cell lung cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2006, v. 55, n. 12, p. 1553, doi. 10.1007/s00262-006-0145-7
- By:
- Publication type:
- Article
A Threefold Dose Intensity Treatment With Ifosfamide, Carboplatin, and Etoposide for Patients With Small Cell Lung Cancer: A Randomized Trial.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2008, v. 100, n. 8, p. 533, doi. 10.1093/jnci/djn088
- By:
- Publication type:
- Article
High sensitivity assays for docetaxel and paclitaxel in plasma using solid-phase extraction and high-performance liquid chromatography with UV detection.
- Published in:
- BMC Clinical Pharmacology, 2006, v. 6, p. 2, doi. 10.1186/1472-6904-6-2
- By:
- Publication type:
- Article
Combining a Universal Telomerase Based Cancer Vaccine With Ipilimumab in Patients With Metastatic Melanoma - Five-Year Follow Up of a Phase I/IIa Trial.
- Published in:
- Frontiers in Immunology, 2021, v. 11, p. N.PAG, doi. 10.3389/fimmu.2021.663865
- By:
- Publication type:
- Article
Long-Term Outcomes of a Phase I Study With UV1, a Second Generation Telomerase Based Vaccine, in Patients With Advanced Non-Small Cell Lung Cancer.
- Published in:
- Frontiers in Immunology, 2020, v. 11, p. N.PAG, doi. 10.3389/fimmu.2020.572172
- By:
- Publication type:
- Article
Assessing quality of life in a randomized clinical trial: Correcting for missing data.
- Published in:
- BMC Medical Research Methodology, 2009, v. 9, p. 1, doi. 10.1186/1471-2288-9-28
- By:
- Publication type:
- Article
Comorbidity and outcomes of concurrent chemo- and radiotherapy in limited disease small cell lung cancer.
- Published in:
- Acta Oncologica, 2016, v. 55, n. 11, p. 1349, doi. 10.1080/0284186X.2016.1201216
- By:
- Publication type:
- Article
Randomized phase II trial comparing twice daily hyperfractionated with once daily hypofractionated thoracic radiotherapy in limited disease small cell lung cancer.
- Published in:
- Acta Oncologica, 2016, v. 55, n. 5, p. 591, doi. 10.3109/0284186X.2015.1092584
- By:
- Publication type:
- Article
Pharmacokinetic analysis of two different docetaxel dose levels in patients with non-small cell lung cancer treated with docetaxel as monotherapy or with concurrent radiotherapy.
- Published in:
- BMC Cancer, 2007, v. 7, p. 197, doi. 10.1186/1471-2407-7-197
- By:
- Publication type:
- Article